Association of Genetic Polymorphism in Dopamine Receptor D2 with Risk of Schizophrenia and Bipolar Disorder: a Meta-Analysis

张明,张钊,魏之昀,贺林,万春玲
DOI: https://doi.org/10.3760/cma.j.issn.1673-4386.2010.01.002
2010-01-01
International Journal of Genetics
Abstract:Genetic components are important risk factors for schizophrenia (SCZ) and bipolar disorder (BP). Emerging evidences showed that dopamine receptor D2 confers susceptibility to SCZ and BP, but many results from different studies are inconsistent. Systematic recta-analysis benefits to avoid false positive or false negative results, which are generally caused by small sampling size. After careful review and analysis, we se-lected 8 independent studies on BP and 49 studies on SCZ, and then we used meta-analysis to clarify the associ-ation between three genetic polymorphisms (141C Del/Ins, TaqI-A and Ser311Cys) of dopamine receptor D2 and SCZ/BP. We found that the Ser311Cys G/C polymorphism is significantly associated with the risk of SCZ, and the TaqI-A T/C polymorphism is significantly associated with the risk of BP (P < 0.05). Genotypic analy-sis showed that the Set311Cys G carrier is a risk factor for SCZ. The TT genotype of TaqI-A polymorphism may be a risk factor for BP,but a protective factor for SCZ.
What problem does this paper attempt to address?